Drugs / Aminoven 10%
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| — | NCT03807583 Comparator | Mar 2019 → Jan 2020 | end stage renal failure | Indigo Therapeutics | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | AMINOVEN 10% | “The AMINOVEN® 10% comparative product is a drug in the form of a 130 mL intravenous infusion solution.” NCT03807583 ↗ |
| Route | Intravenous | “130 mL intravenous infusion solution” NCT03807583 ↗ |